News

2018-07-31

Formosa's customer in mainland China get the 1st Montelukast GQCE approval in Chinese mainland.

2018-07-01

TW Patent No. I628187 entitled Process for preparation of Fondaparinux was granted on July 1, 2018.

2018-02-21

Passed 6th US FDA inspection, a PAI for Sevelamer Carbonate

2018-01-31

The Industrial Development Bureau, Taiwan Ministry of Economic Affairs(MOEA) has announced that "Formosa Laboratories Inc." is recommended as domestic pharmaceutical R & D services provider in Taiwan biotech pharmaceutical industry.

Close